Hotline:
+ 49 (0) 2204 2918806

Market studies for category S

Items 1 to 10 of 214 total

  1. 1
  2. | 2
  3. | 3
  4. | 4
  5. | 5
  6. | 6
  7. | 7
  8. | 8
  9. | 9
  10. | 10
  11. ...
  12. | 22
  1. Net price*
    Year
  2. $250.00
    2014
    Für diese Studie liegt keine Bewertung vor.

    Svelte Medical Systems, Inc. - Medical Equipment - Deals and Alliances Profile

    GlobalData
    24 pages
    Svelte Medical Systems, Inc. (Svelte) is a medical device company. The company develops non-inflammatory Drug Eluting Stent (DES) for cardiac stent procedures. Its products include svelte acrobat stent-on-a-wire bare metal coronary stent, balloon expandable stents and drug eluting stent. Svelte developed three technologies, namely, Integr
    Englisch | Zukunftsanalyse | SKU: 269870
  3. $250.00
    2014
    Für diese Studie liegt keine Bewertung vor.

    Solvias AG - Pharmaceuticals & Healthcare - Deals and Alliances Profile

    GlobalData
    18 pages
    Solvias AG (Solvias) is a pharmaceutical service provider. The company is focused on supporting research and development of drug substances and the optimization of manufacturing processes. Its technology portfolio includes analytical techniques, biopharmaceutical analysis, screening, crystallization, process analytical technology and manu
    Englisch | Zukunftsanalyse | SKU: 331525
  4. $250.00
    2014
    Für diese Studie liegt keine Bewertung vor.

    Sunovion Respiratory Development Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

    GlobalData
    21 pages
    Sunovion Respiratory Development Inc. (Sunovion) is a biopharmaceutical company. The company develops, manufactures, markets and distributes aerosol or inhaled drug products and therapies for patients with respiratory diseases. Its products include eszopiclone, lurasidone HCl, levalbuterol HCl, levalbuterol tartrate, arformoterol tartrate
    Englisch | Zukunftsanalyse | SKU: 358403
  5. $250.00
    2014
    Für diese Studie liegt keine Bewertung vor.

    Syntaxin Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile

    GlobalData
    22 pages
    Syntaxin Ltd (Syntaxin) is a life science company. The company discovers and develops platform that delivers a pipeline of targeted secretion inhibitors (TSI). It develops bacterial based protein therapeutics for the treatment of inflammatory, neurological and endocrine diseases. Syntaxin’s TSI are biological molecules synthesized in mi
    Englisch | Zukunftsanalyse | SKU: 163055
  6. $250.00
    2014
    Für diese Studie liegt keine Bewertung vor.

    Selexys Pharmaceuticals Corporation - Pharmaceuticals & Healthcare - Deals and Alliances Profile

    GlobalData
    15 Pages
    This comprehensive SWOT profile of GungHo Online Entertainment, Inc. provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats.
    Englisch | Zukunftsanalyse | SKU: 310083
  7. $250.00
    2014
    Für diese Studie liegt keine Bewertung vor.

    SunLink Health Systems, Inc. (SSY) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

    GlobalData
    15 pages
    SunLink Health Systems, Inc. (SunLink) is a healthcare service provider. The organization provides healthcare products and services to rural communities. Its services include primary care, personalized care, specialty pharmacy and related healthcare services. SunLink has various hospitals and healthcare centers such as Callaway Community
    Englisch | Zukunftsanalyse | SKU: 331937
  8. $250.00
    2014
    Für diese Studie liegt keine Bewertung vor.

    Stromedix, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

    GlobalData
    18 pages
    Stromedix, Inc. (Stromedix) is a pharmaceutical company. It focuses on the development of novel therapies for the treatment of fibrosis and organ failure. Its product portfolio consists of STX-100, a humanized monoclonal antibody that blocks the activation of TGFß, a key anti-fibrotic cytokine, selectively at sites of tissue injury. The
    Englisch | Zukunftsanalyse | SKU: 338884
  9. $250.00
    2014
    Für diese Studie liegt keine Bewertung vor.

    Swift Energy Company Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2013

    GlobalData
    83 Pages
    Swift Energy Company Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential source for key operational data, analysis and strategi
    Englisch | Zukunftsanalyse | SKU: 136793
  10. $250.00
    2014
    Für diese Studie liegt keine Bewertung vor.

    Spiration, Inc. - Medical Equipment - Deals and Alliances Profile

    GlobalData
    29 pages
    Spiration, Inc., (Spiration) is a medical device company. The company develops and markets minimally invasive medical devices for the treatment of acute and chronic conditions of the lung. Its product is IBV valve system used for the treatment of severe emphysema. Spiration’s valve system is designed to redirect airflow from diseased po
    Englisch | Zukunftsanalyse | SKU: 269922
  11. $250.00
    2014
    Für diese Studie liegt keine Bewertung vor.

    SeniorBridge Family Companies, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

    GlobalData
    22 pages
    SeniorBridge Family Companies, Inc. (SeniorBridge) is a healthcare organization. The hospital provides professional geriatric care management services. Its services include clinical evaluation, medication management, advice and long-term planning, care coordination, care supervision, personal help and assistance, and observation and repor
    Englisch | Zukunftsanalyse | SKU: 331563

Items 1 to 10 of 214 total

  1. 1
  2. | 2
  3. | 3
  4. | 4
  5. | 5
  6. | 6
  7. | 7
  8. | 8
  9. | 9
  10. | 10
  11. ...
  12. | 22